학술논문

A phase II study to explore biomarkers for the use of mFOLFOX6/XELOX plus bevacizumab as a first-line chemotherapy in patients with metastatic colorectal cancer (WJOG7612GTR)

Document Type

Article

Author

Okamoto, W.; Sakai, K.; Makiyama, A.; Yamamoto, Y.; Shitara, K.; Denda, T.; Izawa, N.; Nakano, Y.; Nishina, T.; Esaki, T.; Hara, H.; Miura, Y.; Boku, N.; Yamazaki, K.; Hironaka, S.; Misumi, T.; Hyodo, I.; Muro, K.; Nishio, K.

Source

In ESMO Open December 2022 7(6)

Subject

Language

ISSN

2059-7029

Online Access

Full Text (ScienceDirect 종량제) Full Text (Clinical Key) Full Text (ScienceDirect O/A) Web of Science JCR 저널정보 Scopus Find it@PNU

이메일

부산대학교 도서관

Online Access

메일 발송